IP Library Granted Patent US 11,046,820
Granted Patent B2
US 11,046,820 · App. 16/351,218 · Granted Jun 29, 2021

Three-dimensional polymer networks and their use

Inventors: Holger Klapproth (Freiburg, DE); Sonja Bednar (Gundelfingen, DE)
Assignee: Safeguard Biosystems Holdings Ltd.
C08J3/075B01L3/00C08F12/30C08K3/32C08K5/07C08L25/18C08L33/26G01N33/54366C08F2810/20C08K2003/324C08L2312/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,046,820
App. No.
16/351,218
Granted
Jun 29, 2021
Kind
B2
Abstract

The disclosure provides three-dimensional cross-linked polymer networks transport channels, arrays comprising the networks, processes for making the networks, and uses of the networks and arrays.

Claims (27)

1. An array comprising a plurality of three-dimensional hydrogel networks immobilized on a substrate, wherein the three-dimensional hydrogel networks:

(a) comprise crosslinked water-soluble polymer chains and one or more probe molecules; and

(b) have one or more long transport channels and one or more short transport channels.

2. The array of claim 1 , wherein the water-soluble polymer chains comprise polymer chains polymerized from dimethylacrylamide (DMAA), methacryloyloxybenzophenone (MABP), and sodium 4-vinylbenzenesulfonate (SSNa).

3. The array of claim 1 , wherein the probe molecules are nucleic acid molecules.

4. The array of claim 2 , wherein the probe molecules are nucleic acid molecules.

5. The array of claim 1 , wherein the probe molecules are crosslinked to the crosslinked water-soluble polymer chains.

6. The array of claim 2 , wherein the probe molecules are crosslinked to the crosslinked water-soluble polymer chains.

7. The array of claim 3 , wherein the probe molecules are crosslinked to the crosslinked water-soluble polymer chains.

8. The array of claim 4 , wherein the probe molecules are crosslinked to the crosslinked water-soluble polymer chains.

9. The array of claim 1 , wherein the plurality of three-dimensional hydrogel networks comprises one or more three-dimensional hydrogel networks comprising labeled control probe molecules.

10. The array of claim 9 , wherein the labeled control probe molecules are fluorescently labeled.

11. The array of claim 1 , wherein the three-dimensional hydrogel networks are crosslinked to the substrate.

12. The array of claim 1 , wherein the three-dimensional hydrogel networks are positioned at discrete spots on the substrate.

13. The array of claim 1 , wherein the one or more short transport channels are formed from cubic or rod-shaped salt crystals.

14. The array of claim 1 , wherein at least one of the three-dimensional networks comprises one or more short transport channels penetrated by one or more long transport channels.

15. The array of claim 1 , wherein the one or more long transport channels are formed from needle-shaped salt crystals.

16. The array of claim 13 , wherein the one or more long transport channels are formed from needle-shaped salt crystals.

17. A method for determining whether an analyte is present in a sample, comprising:

(a) contacting the array of claim 1 with the sample, wherein the array comprises one or more three-dimensional hydrogel networks comprising probe molecules that are capable of binding to the analyte; and

(b) detecting binding of the analyte to the probe molecules.

18. The method of claim 17 , wherein the network has been used and washed at least 10 times prior to step (a).

19. The method of claim 17 , which further comprises reusing the network at least 10 times following step (b).

20. The method of claim 17 , which further comprises quantifying binding of the analyte to the probe molecules.

21. The method of claim 17 , wherein the array comprises at least one three-dimensional hydrogel network comprising a fluorescently labelled oligonucleotide as a reusability control.

22. The method of claim 21 , which comprises testing the fluorescent signal strength.

23. The method of claim 22 , wherein the reusability control retains at least 70% of its initial fluorescence signal strength after 10 uses.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2024
From: IP SUCCESSOR FUND 21 L.P.
To: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
Reel/Frame 069084/0644 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2024
From: MLC50 LP INC.
To: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
Reel/Frame 069084/0649 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2024
From: SAFEGUARD BIOSYSTEMS HOLDING LIMITED
To: SAFEGUARD DX LIMITED
Reel/Frame 069088/0245 →
SECURITY INTEREST Recorded Aug 16, 2024
From: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
To: MLC50 LP INC.
Reel/Frame 068317/0453 →
SECURITY INTEREST Recorded Feb 25, 2021
From: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
To: IP SUCCESSOR FUND 21 L.P.
Reel/Frame 055411/0940 →
Priority Claims (1)
EP 17176572 · Jun 19, 2017 · regional
Continuity (2)
Continuation 16011790 · Jun 19, 2018
Related Publication 20190211159A1 · Jul 11, 2019